ADAMTS9 and gastric cancer: The upregulation of ADAMTS9-AS2 suppresses GC advancement and enhances the sensitivity of cisplatin-resistant GC cells to cisplatin by mediating the miR-223-3p/NLRP3 axis, thereby inducing pyroptosis (149).